Analysts expect sales decline Biogen

Tomorrow Biogen will publish its past quarters results. For this year the company, based in Cambridge revenue will be around 9.64 billion USD. This is according to the average of the analysts' estimates. This is slightly lower than 2023's revenue of 9.84 billion USD.

Historical revenues and results Biogen plus estimates 2023

Biogen Badhoevedorp The Netherlands Europe © Biogen

The analysts expect for 2024 a net profit of 2.31 billion USD. According to most of the analysts the company will have a profit per share for this book year of 16.19 USD. The PE-ratio therefore is 11.43.

For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies equals an attractive 3.55 percent.

Biogen 's market value equals around 26.66 billion .

Historical stock prices Biogen

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.